Skip to main content
Clinical Trials/CTRI/2022/10/046861
CTRI/2022/10/046861Not yet recruitingPhase 3

The effect of a microbiome manipulation strategy through dietary exclusion and fecal microbial transplantation in inducing and maintaining remission in patients with mild to moderate Crohnâ??s disease - FMT-CD

ICMR0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor
ICMR

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •1.Age between 18 â?? 70years
  • •2.Patients with mild to moderate clinically active Crohnâ??s disease as assessed by CDAI (150 â?? 450)
  • •3.Patients with terminal ileal/ ileocolonic (limited to terminal ileum)/colonic Crohnâ??s disease (i.e. L1, L2, or L3 disease as per Montreal classification)
  • •4.Patients with inflammatory phenotype (B1) or structuring phenotype (B2) (with absence of stricture symptoms)
  • •5.Evidence of active disease on objective measures including any of endoscopic activity (SES-CD >=3), fecal calprotectin ( >150 µg/gm), or radiological activity(within 3 months)
  • •6.Patients giving consent for FMT
  • •7.Patients who agree to adhere to the diet schedule
  • •8.Patients on stable doses of azathioprine/ 6-mercaptoprine/methotrexate for 4weeks
  • •9.Patients on stable doses of 5-ASA for 4 weeks
  • •10.Patients not on steroids or on low dose steroids less than 20 mg daily of prednisone equivalent.

Exclusion Criteria

  • •1.Patients with proximal small bowel disease (i.e. L4 disease)
  • •2.Patients with severe disease activity
  • •3.Patients with symptomatic strictures
  • •4.Patients with H/O of antibiotic exposure in the past 2weeks
  • •5.Patients with active perianal disease
  • •6.Patients with abdominal abscess/ intestinal fistulae/ acute obstruction
  • •7.Prior intestinal surgery (subtotal or total colectomy, ileostomy, colostomy) or patients planned for surgery (known fixed symptomatic stenosis or complex fistulae)
  • •8.Patients who have been recently initiated (within 3 months) on biologicals or their regimen modified (such as increased frequency) within 3 months
  • •9.Patients requiring hospitalization
  • •10.Pregnancy

Investigators

Sponsor
ICMR

Similar Trials

Completed
Not Applicable
Effect of a Multifaceted Intervention on Blood Pressure Control and Drug ComplianceEssential (primary) hypertension.Essential (primary) hypertensionICD-I10
IRCT20110821007391N6Esfahan University of Medical Sciences72
Recruiting
Phase 2
Comparison of anti-atheroslerotic effects between intensified multifactorial intervention and conventional therapy in patients with coronary artery disease and type 2 diabetesCoronary artery disease with diabetes mellituscoronary artery disease, diabetes mellitus, dyslipidemia, hypertensionD006331
JPRN-jRCTs031200359Hibi Kiyoshi312
Not yet recruiting
Unknown
Effectiveness of hygienic practice Intervention on reducing intestinal parasitic infection among Children in Central Ethiopia Regional State: A Randomized Control TrialDigestive SystemIntestinal parasite infectionPaediatrics
PACTR202404878631304124
Unknown
Not Applicable
Multifactor-adjusted intervention based and deliriumDelirium.Delirium, not induced by alcohol and other psychoactive substances
IRCT201403138286N5Tehran University of Medical Sciences88
Terminated
Not Applicable
Efficacy of complementary interventions in the treatment of Ankylosing SpondylitisQuality of lifeSpinal mobilityLimited thoracic expansionAlternative and Complementary Medicine - Other alternative and complementary medicineInflammatory and Immune System - Autoimmune diseasesPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitationAnkylosing Spondylitis
ACTRN12622001225707niversidad Camilo José Cela12
Assess utility of transferring healthy... | Clinical Trial